Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Ordinary Shares / American Depositary Shares
-
Shares outstanding
-
384M
-
Number of holders
-
11
-
Total 13F shares, excl. options
-
3.09M
-
Shares change
-
+209K
-
Total reported value, excl. options
-
$58.7M
-
Value change
-
+$1.76M
-
Number of buys
-
7
-
Number of sells
-
-8
-
Price
-
$19.02
Significant Holders of Chemomab Therapeutics Ltd. - Ordinary Shares / American Depositary Shares (CMMB) as of Q2 2021
16 filings reported holding CMMB - Chemomab Therapeutics Ltd. - Ordinary Shares / American Depositary Shares as of Q2 2021.
Chemomab Therapeutics Ltd. - Ordinary Shares / American Depositary Shares (CMMB) has 11 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3.09M shares
of 384M outstanding shares and own 0.8% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (2.58M shares), Ikarian Capital, LLC (291K shares), MARSHALL WACE, LLP (63.6K shares), BOOTHBAY FUND MANAGEMENT, LLC (54.7K shares), Marshall Wace North America L.P. (44K shares), MEITAV DASH INVESTMENTS LTD (40.7K shares), Virtu Financial LLC (13.2K shares), Spire Wealth Management (500 shares), MORGAN STANLEY (163 shares), and UBS Group AG (139 shares).
This table shows the top 11 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.